Discontinued — last reported Q4 '25
CoreWeave, Inc. Interest Paid increased by 16.7% to $364.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 156.0%, from $142.19M to $364.00M. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase in interest paid relative to debt levels may signal rising borrowing costs or higher leverage, while a decrease may indicate debt reduction or refinancing at lower rates.
The total cash outflow for interest payments on debt obligations, typically disclosed as a supplemental item in the cash...
Essential for comparing the cost of capital and debt burden across peers in the pharmaceutical industry.
cf_interest_paid| Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $0.00 | $0.00 | $0.00 | $1.97M | $22.89M | $72.56M | $86.57M | $142.19M | $219.36M | $195.57M | $311.88M | $364.00M |
| QoQ Change | — | — | — | — | — | >999% | +217.0% | +19.3% | +64.2% | +54.3% | -10.8% | +59.5% | +16.7% |
| YoY Change | — | — | — | — | — | — | — | — | >999% | +858.3% | +169.5% | +260.2% | +156.0% |